These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 1988428

  • 1. Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions.
    Mirmira RG, Nakagawa SH, Tager HS.
    J Biol Chem; 1991 Jan 25; 266(3):1428-36. PubMed ID: 1988428
    [Abstract] [Full Text] [Related]

  • 2. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
    Nakagawa SH, Tager HS.
    J Biol Chem; 1986 Jun 05; 261(16):7332-41. PubMed ID: 3519607
    [Abstract] [Full Text] [Related]

  • 3. Disposition of the phenylalanine B25 side chain during insulin-receptor and insulin-insulin interactions.
    Mirmira RG, Tager HS.
    Biochemistry; 1991 Aug 20; 30(33):8222-9. PubMed ID: 1868095
    [Abstract] [Full Text] [Related]

  • 4. Role of the phenylalanine B24 side chain in directing insulin interaction with its receptor. Importance of main chain conformation.
    Mirmira RG, Tager HS.
    J Biol Chem; 1989 Apr 15; 264(11):6349-54. PubMed ID: 2649499
    [Abstract] [Full Text] [Related]

  • 5. Role of the COOH-terminal B-chain domain in insulin-receptor interactions. Identification of perturbations involving the insulin mainchain.
    Nakagawa SH, Tager HS.
    J Biol Chem; 1987 Sep 05; 262(25):12054-8. PubMed ID: 3305501
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Shortened insulin with enhanced in vitro potency.
    Casaretto M, Spoden M, Diaconescu C, Gattner HG, Zahn H, Brandenburg D, Wollmer A.
    Biol Chem Hoppe Seyler; 1987 Jun 05; 368(6):709-16. PubMed ID: 3304338
    [Abstract] [Full Text] [Related]

  • 8. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions.
    Shoelson SE, Lu ZX, Parlautan L, Lynch CS, Weiss MA.
    Biochemistry; 1992 Feb 18; 31(6):1757-67. PubMed ID: 1737029
    [Abstract] [Full Text] [Related]

  • 9. Structural integrity of the B24 site in human insulin is important for hormone functionality.
    Žáková L, Kletvíková E, Veverka V, Lepsík M, Watson CJ, Turkenburg JP, Jirácek J, Brzozowski AM.
    J Biol Chem; 2013 Apr 12; 288(15):10230-40. PubMed ID: 23447530
    [Abstract] [Full Text] [Related]

  • 10. Structure-function relationships of des-(B26-B30)-insulin.
    Spoden M, Gattner HG, Zahn H, Brandenburg D.
    Int J Pept Protein Res; 1995 Apr 12; 46(3-4):221-7. PubMed ID: 8537175
    [Abstract] [Full Text] [Related]

  • 11. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes.
    Cara JF, Nakagawa SH, Tager HS.
    Endocrinology; 1988 Jun 12; 122(6):2881-7. PubMed ID: 2967179
    [Abstract] [Full Text] [Related]

  • 12. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions.
    Nakagawa SH, Tager HS.
    Biochemistry; 1992 Mar 31; 31(12):3204-14. PubMed ID: 1554705
    [Abstract] [Full Text] [Related]

  • 13. Extending Halogen-based Medicinal Chemistry to Proteins: IODO-INSULIN AS A CASE STUDY.
    El Hage K, Pandyarajan V, Phillips NB, Smith BJ, Menting JG, Whittaker J, Lawrence MC, Meuwly M, Weiss MA.
    J Biol Chem; 2016 Dec 30; 291(53):27023-27041. PubMed ID: 27875310
    [Abstract] [Full Text] [Related]

  • 14. Analog binding properties of insulin receptor mutants. Identification of amino acids interacting with the COOH terminus of the B-chain of the insulin molecule.
    Mynarcik DC, Williams PF, Schaffer L, Yu GQ, Whittaker J.
    J Biol Chem; 1997 Jan 24; 272(4):2077-81. PubMed ID: 8999905
    [Abstract] [Full Text] [Related]

  • 15. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin.
    Tager H, Thomas N, Assoian R, Rubenstein A, Saekow M, Olefsky J, Kaiser ET.
    Proc Natl Acad Sci U S A; 1980 Jun 24; 77(6):3181-5. PubMed ID: 6997872
    [Abstract] [Full Text] [Related]

  • 16. Semisynthetic insulin analogues modified in positions B24, B25 and B29.
    Svoboda I, Brandenburg D, Barth T, Gattner HG, Jirácek J, Velek J, Bláha I, Ubik K, Kasicka V, Pospísek J.
    Biol Chem Hoppe Seyler; 1994 Jun 24; 375(6):373-8. PubMed ID: 7980868
    [Abstract] [Full Text] [Related]

  • 17. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
    Leyer S, Gattner HG, Leithäuser M, Brandenburg D, Wollmer A, Höcker H.
    Int J Pept Protein Res; 1995 Nov 24; 46(5):397-407. PubMed ID: 8567184
    [Abstract] [Full Text] [Related]

  • 18. Implications of replacing peptide bonds in the COOH-terminal B chain domain of insulin by the psi (CH2-NH) linker.
    Nakagawa SH, Johansen NL, Madsen K, Schwartz TW, Tager HS.
    Int J Pept Protein Res; 1993 Dec 24; 42(6):578-84. PubMed ID: 8307689
    [Abstract] [Full Text] [Related]

  • 19. Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor.
    Kurose T, Pashmforoush M, Yoshimasa Y, Carroll R, Schwartz GP, Burke GT, Katsoyannis PG, Steiner DF.
    J Biol Chem; 1994 Nov 18; 269(46):29190-7. PubMed ID: 7961885
    [Abstract] [Full Text] [Related]

  • 20. [LeuB24]insulin and [AlaB24]insulin: altered structures and cellular processing of B24-substituted insulin analogs.
    Assoian RK, Thomas NE, Kaiser ET, Tager HS.
    Proc Natl Acad Sci U S A; 1982 Sep 18; 79(17):5147-51. PubMed ID: 6752939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.